健康之路拟全球发售2500万股 预期将于12月30日上市

金融界
18 Dec 2024

观点网讯:12月18日,健康之路公告宣布,公司于2024年12月18日-2024年12月23日招股,拟全球发售2500万股,香港公开发售占10%,国际发售占90%。发售价为每股发售股份7.80港元-8.80港元,每手500股,预计股份将于2024年12月30日上市。假设发售价为每股股份8.3港元,全球发售所得款项净额约1.212亿港元。其中,所得款项净额约33.5%拟于未来三年用于业务发展,特别是...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10